Lifestyle
Tesla lends its automation expertise in search for COVID-19 vaccine
Tesla CEO Elon Musk may have strong disagreements over the political handling of the COVID-19 pandemic, but his actions to help solve the matter strike a more positive note, namely one of progress in vaccine technology.
In a recent Twitter discussion about the uptick in national cases, Musk offered his thoughts on using RNA for immunization therapies.
“In principle, I think synthetic RNA (and DNA) has amazing potential,” he replied. “This basically makes the solution to many diseases a software problem.” Musk then brought attention to the current work Tesla is doing via Tesla Grohmann Automation GmbH in Germany. “Tesla, as a side project, is building RNA microfactories for CureVac & possibly others.”
CureVac AG is a German biotechnology company founded in 2000 with the primary goal of using proteins created with stabilized messenger RNA (mRNA) in disease therapeutics. As described on their official website, the company has “…develop[ed] an extensive in-house nucleotide sequence library that allows us to optimally assemble the various pieces of the mRNA puzzle for the desired therapeutic use…Each CureVac product can be thought of as a tailored molecular creation.” The protein-centric nature of these products may enable the development of a wide variety of therapies, including cancer immunotherapy, antibody production, treatments for rare diseases, and prophylactic vaccines.
In principle, I think synthetic RNA (and DNA) has amazing potential. This basically makes the solution to many diseases a software problem.
— Elon Musk (@elonmusk) July 2, 2020
CureVac’s vaccines use a dose of synthetic mRNA coded for disease-specific proteins or antigens which induce the immune system to respond and produce antibodies. Musk’s comment about diseases being a software problem seems to refer in part to this type of technology. The production side of this specialized mRNA looks to be where their relationship with Tesla is formalized. Specifically, the two companies have developed a bioreactor (referred to by Musk as an ‘RNA microfactory’) which combines Tesla Grohmann’s automation technology with CureVac’s tailored mRNA coding and printing.
A press release by CureVac from February 2019 refers to the bioreactor as The RNA Printer™ describing it as “…a transportable, down-scaled, automated messenger RNA (mRNA) printing facility…that can target known pathogens (including Lassa Fever, Yellow Fever, and Rabies) and prepare for rapid response to new and previously unknown pathogens (referred to by WHO as “Disease X”).” Several partnerships and grants have been accumulated by CureVac to further its development of the machine’s capabilities, and the race for a COVID-19 vaccine has brought even more attention and support to the technology.
Although this pandemic has now provided a spotlight on the Tesla and CureVac partnership, a joint patent application for the bioprinter was originally filed in 2018. Published in January this year, the invention is descriptively titled “Bioreactor for RNA in vitro Transcription” and assigned International Patent Publication No. WO-2020/002598. The Background section of the application provides a bit more insight to the technology, its potential, and why Tesla-style automation really makes a difference in what’s possible:
“A critical step in RNA production is the generation of a suitable DNA template, which at industrial scale is a major cost factor…Manufacturing of RNA requires a large degree of manual handling in a GMP-regulated laboratory executed by well-trained technical staff. In consequence, current established manufacturing processes are time consuming, cost intensive, and require a lot of laboratory space and laboratory equipment.”
Essentially, automating much of the manufacturing process would improve speed and reduce errors from human interaction, just as is the case with Tesla’s automated car manufacturing. Unlike automotive large-scale productions, however, this bioprinter would be much smaller. With staffing needs reduced and the equipment needs reduced to a single machine, portability comes into play.
“…an acceleration of RNA manufacturing would be highly advantageous and of major importance for public health, especially in the context of pandemic scenarios. Further advantageous in that context would be the production of the RNA therapeutics in the region of the outbreak which would, however, require a portable RNA production apparatus.”
It’s not clear exactly which parts of the invention were specifically Tesla’s contribution aside from Musk’s indication that his company would be manufacturing the machines.
Overall, as stated in CureVac’s press release, The RNA Printer™ will be capable of producing enough customized mRNA for 100,000+ vaccine doses within a few weeks and on-site of the outbreak location. The same machine would be flexible enough to be used for a wide variety of pathogens. Notably, CureVac was recently cleared for phase I human trials of its mRNA vaccine for COVID-19.
Musk’s interest in biotechnology is well known to those who follow his many projects and businesses, especially in terms of artificial intelligence as it relates to human-computer interfaces via Neuralink. However, this more traditional philanthropic involvement is surely quite welcome in a world turned upside down by a pandemic.
Elon Musk
Tesla ditches India after years of broken promises
Tesla has ditched its plans to build a factory in India after years of failed negotiations.
Tesla’s long-running effort to establish a manufacturing presence in India is officially over. India’s Minister of Heavy Industries H.D. Kumaraswamy confirmed on May 19, 2026 that Tesla has informed authorities it will not proceed with a manufacturing facility in the country.
Tesla first signaled serious interest in India around 2021, when it began hiring local staff and lobbying the Indian government for lower import tariffs. The ask was straightforward: reduce duties enough for Tesla to test the market with imported vehicles before committing capital to a local factory. India’s position was equally firm, with an ask of Tesla to commit to manufacturing first, then receive tariff relief. Neither side moved, and the talks quietly collapsed.
Tesla to open first India experience center in Mumbai on July 15
India had offered a policy that would reduce import duties from 110% down to 15% on EVs priced above $35,000, provided companies committed at least $500 million toward local manufacturing investment within three years. Tesla declined to participate. The tariff standoff was only part of the problem. Analysts pointed to significant gaps in India’s local supply chain, inadequate industrial infrastructure, and a mismatch between Tesla’s premium pricing and the purchasing power of India’s automotive market as additional factors that made the investment difficult to justify.
First signs of an unraveling relationship came in April 2024, when Musk abruptly cancelled a planned trip to India where he was set to meet Prime Minister Modi and announce Tesla’s market entry. By July 2024, Fortune reported that Tesla executives had stopped contacting Indian government officials entirely. The government at that point understood Tesla had capital constraints and no plans to invest.
The more fundamental issue is that Tesla’s existing factories are currently operating at approximately 60% capacity, making a commitment to building new manufacturing capacity in a new market difficult to defend to investors. Tesla will continue selling imported Model Y vehicles through its existing showrooms in Mumbai, Delhi, Gurugram, and Bengaluru, but local production is no longer part of the plan.
Elon Musk
Trump’s invite for Elon just reshuffled Tesla’s big Signature Delivery Event
Tesla rescheduled its final Model S farewell to May 20 after Musk joined Trump in China.
Tesla has rescheduled its Model S and Model X Signature Edition delivery event to Wednesday, May 20, 2026, after abruptly calling off the original May 12 celebration. The event will take place at Tesla’s factory at 45500 Fremont Boulevard in Fremont, California, the same location where the Model S first rolled off the line in 2012. Invitees received a follow-up email asking them to reconfirm attendance and download a new QR code ticket, with Tesla noting that all travel and accommodation expenses remain the buyer’s responsibility.
The reason behind the original cancellation came into focus the same day it was announced. President Trump invited Elon Musk, Apple’s Tim Cook, BlackRock’s Larry Fink, Boeing’s Kelly Ortberg, and executives from Goldman Sachs, Blackstone, Citigroup, and Meta to join his trip to China this week for a summit with President Xi Jinping. The agenda covers trade, artificial intelligence, export controls, Taiwan, and the Iran war, following weeks of escalating friction between Washington and Beijing over AI technology, sanctions, and rare earth exports. Trump wrote on Truth Social, “I am very much looking forward to my trip to China, an amazing Country, with a Leader, President Xi, respected by all.”
Tesla launches 200mph Model S “Gold” Signature in invite-only purchase
The vehicles at the center of all this are the last Model S and Model X units Tesla will ever build. Priced at $159,420 each, the 250 Model S and 100 Model X Signature Edition units come finished in Garnet Red with a one-year no-resale agreement, giving Tesla right of first refusal if the owner decides to sell. As Teslarati reported, the Model S defined Tesla’s early identity as a serious luxury automaker, and the Fremont factory line that built it is now being converted to manufacture Optimus humanoid robots.
Musk’s inclusion in the China delegation drew attention given his very public relationship with Trump, and the invitation signals the two have moved past and past grievances. Trump originally brought Musk on to lead the Department of Government Efficiency following his inauguration, and despite a sharp public dispute in mid-2025, the two have appeared together repeatedly in recent months. A seat on the China trip, the most diplomatically consequential visit of Trump’s current term, puts Musk back at the table on U.S. economic policy at a moment when Tesla’s China revenue remains one of the company’s most important financial pillars.
Lifestyle
Tesla Semi hauls fresh Cybercab batch as Robotaxi era takes hold
A Tesla Semi was filmed hauling Cybercab units out of Giga Texas for the first time.
A Tesla Semi loaded with Cybercab units was recently filmed leaving Gigafactory Texas, marking what appears to be the first documented delivery run of Tesla’s autonomous two-seater. The footage shows multiple Cybercabs secured on a flatbed trailer being hauled by a production Tesla Semi, a truck rated for a gross combination weight of 82,000 lbs. The location is consistent with Giga Texas in Austin, where Cybercab production has been ramping since February 2026.
The sighting follows a wave of Cybercab activity at the Austin facility. In late April, drone operator Joe Tegtmeyer spotted approximately 60 Cybercabs parked in two organized groups in the factory’s outbound lot, the largest concentration observed to date. Units being staged in an outbound lot is a standard pre-delivery step, and the Semi footage is the logical next frame in that sequence.
En route with @tesla_semi pic.twitter.com/ZfuOjaeLH1
— Tesla Robotaxi (@robotaxi) May 7, 2026
This is not the first time Tesla has used its own Semi to move Tesla products. When the Semi was unveiled in 2017, Musk noted it would be used for Tesla’s own operations, and over the years Semi prototypes were spotted carrying cargo ranging from concrete weights to Tesla vehicles being delivered to consumers. In 2023, a Semi was photographed transporting a Cybertruck on a trailer ahead of that vehicle’s delivery launch.
The Cybercab itself was first revealed publicly at Tesla’s “We, Robot” event on October 10, 2024, at Warner Bros. Studios in Burbank, where 20 pre-production units gave attendees rides around the studio lot. Musk stated at the event that Tesla intends to produce the Cybercab before 2027. The first production unit rolled off the Giga Texas line on February 17, 2026, with Musk posting on X: “Congratulations to the Tesla team on making the first production Cybercab.”
Tesla’s annual production goal is 2 million Cybercabs per year once multiple factories reach full design capacity, with the company targeting a price under $30,000 per unit. Tesla has confirmed plans to expand its robotaxi service to seven cities in the first half of 2026, including Dallas, Houston, Phoenix, Miami, Orlando, Tampa, and Las Vegas, building on the unsupervised service already running in Austin. Musk has said he expects robotaxis to cover between a quarter and half of the United States by end of year.
Elon Musk called it Epic: The full story of SpaceX’s Starship Flight 12
Zuckerberg’s Meta taps Musk’s Tesla for massive clean energy project
